Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1995 Dec;54(12):944–947. doi: 10.1136/ard.54.12.944

Early rheumatoid arthritis: time to aim for remission?

P Emery 1, M Salmon 1
PMCID: PMC1010056  PMID: 8546524

Full text

PDF
944

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Elliott M. J., Maini R. N., Feldmann M., Kalden J. R., Antoni C., Smolen J. S., Leeb B., Breedveld F. C., Macfarlane J. D., Bijl H. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet. 1994 Oct 22;344(8930):1105–1110. doi: 10.1016/s0140-6736(94)90628-9. [DOI] [PubMed] [Google Scholar]
  2. Emery P., Salmon M., Bradley H., Wordsworth P., Tunn E., Bacon P. A., Waring R. Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis. BMJ. 1992 Dec 5;305(6866):1387–1389. doi: 10.1136/bmj.305.6866.1387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Emery P. The Roche Rheumatology Prize Lecture. The optimal management of early rheumatoid disease: the key to preventing disability. Br J Rheumatol. 1994 Aug;33(8):765–768. doi: 10.1093/rheumatology/33.8.765. [DOI] [PubMed] [Google Scholar]
  4. Gough A. K., Lilley J., Eyre S., Holder R. L., Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet. 1994 Jul 2;344(8914):23–27. doi: 10.1016/s0140-6736(94)91049-9. [DOI] [PubMed] [Google Scholar]
  5. Gough A., Faint J., Salmon M., Hassell A., Wordsworth P., Pilling D., Birley A., Emery P. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum. 1994 Aug;37(8):1166–1170. doi: 10.1002/art.1780370809. [DOI] [PubMed] [Google Scholar]
  6. Kavanaugh A. F., Davis L. S., Nichols L. A., Norris S. H., Rothlein R., Scharschmidt L. A., Lipsky P. E. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum. 1994 Jul;37(7):992–999. doi: 10.1002/art.1780370703. [DOI] [PubMed] [Google Scholar]
  7. Liu Z. G., Smith S. W., McLaughlin K. A., Schwartz L. M., Osborne B. A. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature. 1994 Jan 20;367(6460):281–284. doi: 10.1038/367281a0. [DOI] [PubMed] [Google Scholar]
  8. Matthews N., Emery P., Pilling D., Akbar A., Salmon M. Subpopulations of primed T helper cells in rheumatoid arthritis. Arthritis Rheum. 1993 May;36(5):603–607. doi: 10.1002/art.1780360505. [DOI] [PubMed] [Google Scholar]
  9. Pincus T., Callahan L. F., Sale W. G., Brooks A. L., Payne L. E., Vaughn W. K. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum. 1984 Aug;27(8):864–872. doi: 10.1002/art.1780270805. [DOI] [PubMed] [Google Scholar]
  10. Scott D. L., Symmons D. P., Coulton B. L., Popert A. J. Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet. 1987 May 16;1(8542):1108–1111. doi: 10.1016/s0140-6736(87)91672-2. [DOI] [PubMed] [Google Scholar]
  11. Tugwell P., Pincus T., Yocum D., Stein M., Gluck O., Kraag G., McKendry R., Tesser J., Baker P., Wells G. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. N Engl J Med. 1995 Jul 20;333(3):137–141. doi: 10.1056/NEJM199507203330301. [DOI] [PubMed] [Google Scholar]
  12. Tunn E. J., Bacon P. A. Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheumatol. 1993 Feb;32(2):97–103. doi: 10.1093/rheumatology/32.2.97. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES